From Leaflets to Labels: How Booklet Labels Are Replacing Inserts in Regulated Industries
For decades, regulated industries like pharmaceuticals, chemicals, and agrochemicals have relied on printed inserts and leaflets to deliver critical product information. These supplemental materials are often required by law to inform end-users about ingredients, usage instructions, safety warnings, and legal disclaimers. But as packaging demands evolve and supply chains become more combooplex, companies are rethinking […]
What Are Peel and Reveal Labels – and Why Are They Booming in Pharma and Cosmetics?
You’re in a pharmacy, holding a tiny bottle of medication. The label looks simple—until you peel back a layer and reveal a detailed dosage guide, multilingual instructions, and safety warnings. This is called a peel and reveal label, and it’s changing how regulated products communicate with consumers. In industries like pharmaceuticals and cosmetics, where space […]
The NHS’s Bilingual Peel and Reveal labels
In the vast landscape of healthcare innovation, it’s often the quieter, less glamorous solutions that make the biggest difference. One such example is the introduction of bilingual Peel and Reveal labels within the NHS—a deceptively simple solution addressing a critical issue in patient communication and safety. Peel and Reveal labels might look like ordinary product […]
What Are Peel and Reveal Labels – and Why Are They Booming in Pharma and Cosmetics?
You’re in a pharmacy, holding a tiny bottle of medication. The label looks simple—until you peel back a layer and reveal a detailed dosage guide, multilingual instructions, and safety warnings. This is called a peel and reveal label, and it’s changing how regulated products communicate with consumers. In industries like pharmaceuticals and cosmetics, where space […]
Changing Pharmaceutical EU Laws and What it Means for Peel and Reveal Labels
MEPs adopted their proposals to revamp EU pharmaceutical legislation, to foster innovation and enhance the security of supply, accessibility and affordability of medicines. The legislative package, covering medicinal products for human use, consists of a new directive and regulation. MEPs want to introduce a minimum regulatory data protection period (during which other companies cannot access […]